Drugs / trimethoprim/sulfamethoxazole
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05726318 Background | Feb 2023 → Aug 2024 | urinary tract infection | Megan Bradley | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | trimethoprim/sulfamethoxazole | “trimethoprim/sulfamethoxazole 875/125 oral twice a day for 3 days” NCT05726318 ↗ |
| Route | Oral | “trimethoprim/sulfamethoxazole 875/125 oral twice a day for 3 days” NCT05726318 ↗ |